Future Market Insights, a leading market research firm, predicts a surge in the global automated cell biology systems market. Fueled by advancements in technology and a rising tide of laboratory automation, the market is poised for a remarkable Compound Annual Growth Rate (CAGR) of 9.0% over the next decade. This translates to a projected market valuation of a staggering US$ 33.5 Billion by 2032, up from the current estimate of US$ 14.1 Billion.
This phenomenal growth signifies a major transformation within the biotechnology sector. The widespread adoption of automated cell biology systems is revolutionizing research and production capabilities, paving the way for a new era of scientific discovery and innovation.
Request A Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-15816
Key Takeaways from the Report:
- The global automated cell biology systems market is expected to reach US$ 33.5 Billion by 2032, growing at a CAGR of 9.0%.
- This growth is driven by the increasing adoption of laboratory automation and the development of powerful new technologies and applications.
- Automated cell biology systems are transforming the way research is conducted and production is carried out in the biotechnology sector.
“Rising Demand for Personalized Medicine, and Growth in Total Lab Automation Techniques will Propel Overall Market Growth,” Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)
Key Drivers of Market Growth:
- Rising demand for personalized medicine: Personalized medicine requires efficient and cost-effective cell manipulation techniques, which automated systems can offer.
- Increased investments in cell biology research: Growing awareness of the potential of cell-based therapies and regenerative medicine is fueling research activities.
- Technological advancements: Advancements in robotics, microfluidics, and artificial intelligence are leading to the development of more sophisticated and user-friendly automated systems.
- Growing prevalence of chronic diseases: The increasing burden of chronic diseases like cancer and diabetes is driving the demand for novel therapeutic approaches, often involving cell-based therapies.
Our Methodology-Derived Insights: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-15816
Market Competition:
Automated cell biology system manufacturers have been substantially investing in research to offer long-term solutions for both the biopharmaceutical and packaging industries. Players in the automated cell biology systems market are also focusing on innovations and alliances to strengthen their market position.
For instance:
- In September 2022, Thermo Fisher Scientific Inc. launched the Thermo Scientific™ DynaSpin™ Single-Use Centrifuge system.
- Corning Incorporated introduced a reliable method for differentiating monocytes into dendritic cells in October 2019 with the introduction of Corning® MicroDEN, an automated perfusion cell culture system.
Key Companies Profiled:
- Thermo Fisher Scientific
- Corning Incorporated
- Merck KGaA
- Lonza
- Sartorius AG
- Hitachi. Ltd
- Nanoentek
- ChemoMetec
- Danaher corporation
- Agilent Technologies
- Perkin Elmer (Nexcelom Bioscience LLC.)
- F. Hoffmann-La Roche AG
- SHIMADZU CORPORATION
- Bio-Rad Laboratories
- Miltenyi Biotec
- Sinfonia Technology
Purchase Now to Access Premium Information: https://www.futuremarketinsights.com/checkout/15816
Key Market Segments Covered in Automated Cell Biology Systems Industry Research:
By Product:
- Cell Culture Process Automatization Instrument or Robot (Multiple Function)
- Automated Bioreactor (Single or Multiple Function)
- Automated Cell Culture Media Exchange System (Single Function)
- Automated Culture Media Analyzer (Single Function)
- Automated Cell Wash-and-Concentrate System (Single Function)
- Automated Cell Counter (Single Function)
- Automated Fill And Finish System (Single Function)
- Automated Cell Storage Equipment (Single Function)
- Management Software
By Cell Culture:
- Finite Cell Line Cultures
- Infinite Cell Line Cultures
By Application:
- Cell Therapy
- Drug Development
- Stem Cell Research
- Regenerative Medicine
By End User:
- Mega Pharmaceutical companies
- Biopharmaceutical companies
- CDMOs/CMOs
- Research organizations
- Academic institutes
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube